About astrazeneca plc - AZNCF
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
AZNCF At a Glance
AstraZeneca PLC
Cambridge Biomedical Campus
Cambridge, Cambridgeshire CB2 0AA
| Phone | 44-20-3749-5000 | Revenue | 45.81B | |
| Industry | Pharmaceuticals: Major | Net Income | 5.96B | |
| Sector | Health Technology | 2023 Sales Growth | 3.292% | |
| Fiscal Year-end | 12 / 2024 | Employees | 89,900 | |
| View SEC Filings |
AZNCF Valuation
| P/E Current | 30.528 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 35.15 |
| Price to Sales Ratio | 4.607 |
| Price to Book Ratio | 5.351 |
| Price to Cash Flow Ratio | 19.852 |
| Enterprise Value to EBITDA | 16.295 |
| Enterprise Value to Sales | 5.103 |
| Total Debt to Enterprise Value | 0.122 |
AZNCF Efficiency
| Revenue/Employee | 509,577.308 |
| Income Per Employee | 66,240.267 |
| Receivables Turnover | 3.838 |
| Total Asset Turnover | 0.464 |
AZNCF Liquidity
| Current Ratio | 0.82 |
| Quick Ratio | 0.643 |
| Cash Ratio | 0.195 |
AZNCF Profitability
| Gross Margin | 73.949 |
| Operating Margin | 20.543 |
| Pretax Margin | 15.086 |
| Net Margin | 12.999 |
| Return on Assets | 6.027 |
| Return on Equity | 15.634 |
| Return on Total Capital | 8.788 |
| Return on Invested Capital | 9.676 |
AZNCF Capital Structure
| Total Debt to Total Equity | 73.122 |
| Total Debt to Total Capital | 42.237 |
| Total Debt to Total Assets | 28.305 |
| Long-Term Debt to Equity | 59.326 |
| Long-Term Debt to Total Capital | 34.268 |
Astrazeneca Plc in the News
J&J COVID-19 vaccine manufacturing halted at US plant that had contamination issue
Production of Johnson & Johnson’s (JNJ.N) COVID-19 vaccine at a U.S. manufacturing plant was halted by the U.S. Food and Drug Administration while the agency investigates an error that led to millions of doses being ruined last month.